Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,990 public trials 1,836 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Iodine I 131 Tositumomab

NCT00240578

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Not specified

View Trial Details

Completed

Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor

NCT00582933

Conditions: Allogeneic Marrow Transplant, Bone Marrow Diseases, Hematologic Diseases, +13 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

NCT00387959

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's Lymphoma

NCT00255723

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

PACE CALL: Weight Loss Study for Childhood Leukemia Survivors

NCT01253720

Conditions: Acute Lymphoblastic Leukemia, Body Weight, Cancer, +18 more
Locations: UC San Diego La Jolla, California, United States

View Trial Details

Completed

Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma

NCT00003631

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +10 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma (NHL)

NCT00179660

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Pacific Coast Hematology/Oncology Medical Group, Onc. Fountain Valley, California, United States

UC David Cancer Center Sacramento, California, United States

Sylvester Cancer CenterUniversity Of Miami Miami, Florida, United States

View Trial Details

Completed

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients

NCT01169584

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Virus Infections, Ewing's Sarcoma, +54 more
Locations: Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Completed

LAL-BR/2001: Study Treatment to Low Risk ALL

NCT00526175

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations: Hospital General de Alicante Alicante, Spain

Hospital Valle Hebrón-Materno Infantil Barcelona, Spain

Complejo Hospitalario Reina Sofía Córdoba, Spain

Hospital Clínico San Carlos de Madrid Madrid, Spain

View all 25 locations

View Trial Details

Completed

Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL)

NCT01419691

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +17 more
Locations: University of Kansas Cancer Center Westwood, Kansas, United States

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions